<DOC>
	<DOCNO>NCT01435057</DOCNO>
	<brief_summary>In project , investigator test hypothesis predominant ( two three time week 60 min ) strength train effective reduce visceral fat mass endurance train obese patient .</brief_summary>
	<brief_title>Effects Different Exercise Training Regimens Visceral Fat Dynamic Resting Energy Expenditure Obese Patients</brief_title>
	<detailed_description>Strength training ( ST ) show effective endurance training ( ET ) improve glycemic control treatment type 2 diabetes . However , unknown , whether different train strategy different effect preferential visceral adipose tissue reduction change rest energy expenditure population abdominal obesity . We therefore compare ST ET ( two three time week , 60 minute per training session ) addition restrict energy intake 1500kcal per day woman 1800kcal per day men prospective study 200 individual abdominal obesity define waist circumference &gt; 102 cm male &gt; 88 cm female BMI &gt; 35 kg/mÂ² regard : 1 . Abdominal visceral adipose tissue area dynamic ( MRI study ) 2 . Abdominal subcutaneous adipose tissue area dynamic ( MRI study ) 3 . Total body fat mass change ( bioelectrical impedance analysis ) 4 . Changes rest energy expenditure ( indirect calorimetry ) 5 . Changes parameter glucose metabolism , insulin sensitivity lipid profile 6 . Changes circulate adipokines marker inflammation In addition , search novel serum parameter , predict individual training response serum metabolomics/ proteomics approach .</detailed_description>
	<mesh_term>Obesity , Abdominal</mesh_term>
	<criteria>BMI &gt; = 35 kg/m2 waist circumference &gt; 102cm ( men ) , &gt; 88cm ( woman ) age 18 60 year write informed consent type 1 type 2 diabetes fast plasma glucose &gt; = 6.0 mmol/l 2hOGTT ( oral glucose tolerance test ) glucose &gt; = 11.1 mmol/l chronic inflammatory malignant disease medical treatment influence glucose metabolism drug alcohol abuse psychiatric disorder untreated thyroid dysfunction cardiac pacemaker contraindication MRI attendant therapy oral antidiabetic medication , GLP1 mimetics analoga , Insulin , antiobesity medication ( orlistat , sibutramine ) , Falithrom , antipsychotic drug , chemotherapeutics pregnant nursing woman expect low compliance current participation another investigational trial last exercise training &lt; = 6 month ago</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Abdominal Obesity</keyword>
	<keyword>training</keyword>
	<keyword>fat</keyword>
	<keyword>insulin</keyword>
	<keyword>glucose</keyword>
	<keyword>diet</keyword>
</DOC>